These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 13175400)
21. [The myth of climacteric]. Furuhjelm M Lakartidningen; 1992 Apr; 89(18):1558. PubMed ID: 1579019 [No Abstract] [Full Text] [Related]
22. [HORMONAL TREATMENT OF DISORDERS OF THE CLIMACTERIC]. CONTE JC Sem Med; 1963 Nov; 123():1708-16. PubMed ID: 14111254 [No Abstract] [Full Text] [Related]
23. [Intravenous testosterone in regional circulatory disturbances due to ovarian dysfunction in the climacteric]. FAUDA C; GIACOMINI M Minerva Med; 1949 Oct; 40(52):575-80. PubMed ID: 15394757 [No Abstract] [Full Text] [Related]
24. [CLINICAL ASPECTS AND TREATMENT OF THE FEMALE CLIMACTERIC]. BALSALOBRERUIZ A Folia Clin Int (Barc); 1963; 13():379-81. PubMed ID: 14177039 [No Abstract] [Full Text] [Related]
26. TESTOSTERONE test for the male climacteric. Whats New; 1953; 180():41-2. PubMed ID: 24542850 [No Abstract] [Full Text] [Related]
27. [Contribution to the study of the preventive treatment of surgical menopause by combined testosterone-estradiol]. ESCARRAS A; MARMOTTANS A Mars Chir; 1950; 2(4):625-8. PubMed ID: 14805409 [No Abstract] [Full Text] [Related]
28. [Endocrine aspects of the female climacteric]. Ciarrocchi F; Coniglio M; Lauro S; Di Lellio BM; Minnozzi M; Saitto C; Custo GM Minerva Ginecol; 1988 May; 40(5):307-10. PubMed ID: 3143951 [No Abstract] [Full Text] [Related]
29. Suppression of adrenal metabolism of 4-14C-progesterone by testosterone-oxime and 17a-methyltestosterone-oxime in vitro. Rembiesa R; Marchut M Biochem Pharmacol; 1969 Apr; 18(4):701-6. PubMed ID: 5788513 [No Abstract] [Full Text] [Related]
33. [Estrogen metabolism and hormone substitution in the climacteric]. Göretzlehner G; Kyank H Zentralbl Gynakol; 1985; 107(16):977-88. PubMed ID: 2996259 [TBL] [Abstract][Full Text] [Related]
34. Metabolism of progesterone-4-C14 in a postmenopausal woman with a biliary fistula. WIEST WG; FUJIMOTO GI; SANDBERG AA J Clin Endocrinol Metab; 1958 Sep; 18(9):972-80. PubMed ID: 13575514 [No Abstract] [Full Text] [Related]
35. [The transformation of testosterone into estrogen in the female body; preliminary note]. Netter A; Henry R; Lambert A; Lumbao P; Thevenet M; Mauvais P Ann Endocrinol (Paris); 1958; 19(4):789-91. PubMed ID: 13606489 [No Abstract] [Full Text] [Related]
36. [Rectal administration of progesterone]. NIZZA M; GIARDINELLI M Minerva Ginecol; 1955 Jul; 7(13):167-9. PubMed ID: 13265269 [No Abstract] [Full Text] [Related]
37. The influence of premenopausal hormones on severity of climacteric symptoms and use of HRT. Fentiman IS; Allen D; Wheeler M; Rymer J Climacteric; 2006 Apr; 9(2):135-45. PubMed ID: 16698660 [TBL] [Abstract][Full Text] [Related]
38. [USE OF SEX HORMONES IN ATHEROSCLEROSIS]. MIASNIKOV LA Sov Med; 1963 Nov; 27():33-6. PubMed ID: 14137990 [No Abstract] [Full Text] [Related]
39. Complications of testosterone therapy in the female; the use of methylandrostenediol as a substitute. ROBINSON WW West J Surg Obstet Gynecol; 1953 Feb; 61(2):79-82. PubMed ID: 13029453 [No Abstract] [Full Text] [Related]
40. [Effect of mestranol on carbohydrate and lipid metabolism in the post-menopause period]. Göretzlehner G; Kyank H; Herre H; Töwe J Z Alternsforsch; 1974; 29(1):89-98. PubMed ID: 4464694 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]